#GBMNews ⚠️ | ⁠Progress is underway with the FDA’s approval of a pilot study testing Alpha DaRT, a new and promising radiation therapy for recurrent glioblastoma. This innovative treatment aims to precisely target tumors while protecting healthy brain tissue, offering hope where options are limited. The study marks a meaningful step forward in advancing care for one of the most challenging brain cancers.⁠ ⁠ Learn more by visiting https://www.curetoday.com/view/fda-approves-initiation-of-a-new-trial-in-recurrent-glioblastoma⁠!⁠ ⁠ Source: Cure Today ⁠ ⁠ #GlioblastomaResearch #Glioblastoma #GlioblastomaAwarenessDay (fb)

We’re wrapping up Brain Tumor Awareness Month feeling inspired, energized, and grateful. 🩶 Throughout May, the GBMRO community came together through several impactful partnerships that uplifted those affected by glioblastoma. We sincerely appreciate each and every partner, collaborator, and supporter. With your continued support, hope grows - and so does the progress toward a cure! #BrainTumorAwarenessMonth #GBMRO #GlioblastomaAwareness (fb)